Mamun, SM Abdullah Al, et al. “Rationale of Using Common Antifibrotic Therapy in Post COVID Fibrosis”. Journal of Medicine, vol. 22, no. 1, Jan. 2021, pp. 46-50, doi:10.3329/jom.v22i1.51391.